Lexaria Bioscience Corp.
LEXX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348362
No open-market purchases or sales by Lexaria Bioscience Corp. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $920.0K in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Lexaria Bioscience Corp. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +4 vs. Q2 2025
- Shares held
- 1.72M
- −580.1K (−25.3%) vs. Q2 2025
- Total value
- $1.63M
- −$364.7K (−18.2%) vs. Q2 2025
- New holders
- 7
- 6 more added
- Sold out
- 3
- 2 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LEXX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $920.0K |
| Q1 2026 | 28 | $1.17M |
| Q4 2025 | 21 | $1.05M |
| Q3 2025 | 25 | $1.63M |
| Q2 2025 | 21 | $2.00M |
| Q1 2025 | 22 | $2.12M |
| Q4 2024 | 25 | $3.03M |
| Q3 2024 | 27 | $3.25M |
| Q2 2024 | 28 | $5.72M |
| Q1 2024 | 25 | $3.23M |
| Q4 2023 | 20 | $1.49M |
| Q3 2023 | 15 | $1.77M |
| Q2 2023 | 14 | $651.4K |
| Q1 2023 | 17 | $1.85M |
| Q4 2022 | 16 | $1.71M |
| Q3 2022 | 16 | $1.68M |
| Q2 2022 | 16 | $1.67M |
| Q1 2022 | 12 | $1.41M |
| Q4 2021 | 13 | $1.85M |
| Q3 2021 | 11 | $2.83M |
| Q2 2021 | 10 | $2.93M |
| Q1 2021 | 9 | $1.78M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Lexaria Bioscience Corp.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| The PNC Financial Services Group, Inc. | 6 | $6 | 0.00% | +6 | New |
| Gables Capital Management Inc. | 13 | $12 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 166 | $158 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 173 | $164 | 0.00% | +5+3.0% | Added |
| Rockefeller Capital Management L.P. | 200 | $191 | 0.00% | +200 | New |
| Federation des caisses Desjardins du Quebec | 382 | $362 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 429 | $409 | 0.00% | +429 | New |
| Advisor Group Holdings, Inc. | 2,190 | $2.12K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,622 | $3.45K | 0.00% | +1,658+84.4% | Added |
| UBS Group AG | 7,090 | $6.76K | 0.00% | +1,016+16.7% | Added |
| Royal Bank of Canada | 7,283 | $7.00K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 10,100 | $9.62K | 0.00% | +10,100 | New |
| Bank of Montreal | 14,033 | $13.3K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 18,389 | $17.5K | 0.00% | 00.0% | Unchanged |
| Krilogy Financial LLC | 19,653 | $21.2K | 0.00% | +19,653 | New |
| BlackRock, Inc. | 27,445 | $26.1K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 29,360 | $28.0K | 0.00% | +29,360 | New |
| Byrne Asset Management LLC | 31,320 | $29.8K | 0.02% | −2,889−8.4% | Reduced |
| Wealth Enhancement Advisory Services, LLC | 35,776 | $29.9K | 0.00% | +5,000+16.2% | Added |
| State Street Corp | 39,301 | $37.4K | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 140,013 | $133.5K | 0.00% | +6,888+5.2% | Added |
| Geode Capital Management, LLC | 174,779 | $166.5K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 258,816 | $246.7K | 0.00% | +125,262+93.8% | Added |
| Murchinson Ltd. | 419,590 | $399.7K | 0.08% | +419,590 | New |
| Invenomic Capital Management LP | 477,201 | $454.6K | 0.02% | −24,267−4.8% | Reduced |
| Sabby Management, LLC | 0 | $0 | 0.00% | −1,165,144−100.0% | Sold out |
| Oakworth Capital, Inc. | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |